| scholarly article | Q13442814 |
| P50 | author | Alexander Brawanski | Q50638383 |
| Fabian Pohl | Q115297375 | ||
| P2093 | author name string | Alexander Brawanski | |
| Marsha J Merrill | |||
| Martin A Proescholdt | |||
| Eva-Maria Stoerr | |||
| Annette Lohmeier | |||
| P2860 | cites work | Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships | Q28115959 |
| The catalytic properties of human carbonic anhydrase IX | Q28202087 | ||
| Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment | Q28247998 | ||
| Malignant gliomas in adults | Q29615708 | ||
| Mapping extracellular pH in rat brain gliomas in vivo by 1H magnetic resonance spectroscopic imaging: comparison with maps of metabolites. | Q30659238 | ||
| Human tumour-associated cell adhesion protein MN/CA IX: identification of M75 epitope and of the region mediating cell adhesion | Q30875554 | ||
| Carbonic anhydrase IX in oligodendroglial brain tumors | Q33313215 | ||
| Design, solid-phase synthesis, and biological evaluation of novel 1,5-diarylpyrrole-3-carboxamides as carbonic anhydrase IX inhibitors. | Q33706074 | ||
| Role of hypoxia and EGF on expression, activity, localization and phosphorylation of carbonic anhydrase IX in MDA-MB-231 breast cancer cells | Q34459093 | ||
| Biochemical characterization of CA IX, one of the most active carbonic anhydrase isozymes. | Q34808815 | ||
| Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. | Q35746400 | ||
| Expression of hypoxia-inducible carbonic anhydrases in brain tumors | Q35800142 | ||
| Regulation and function of aquaporin-1 in glioma cells | Q36012580 | ||
| High glycolysis in gliomas despite low hexokinase transcription and activity correlated to chromosome 10 loss | Q36136081 | ||
| Clinging to life: cell to matrix adhesion and cell survival | Q36301231 | ||
| Regulation of tumor pH and the role of carbonic anhydrase 9. | Q36784373 | ||
| Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme | Q36952855 | ||
| Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan | Q37594926 | ||
| New insights into the physiological role of carbonic anhydrase IX in tumour pH regulation | Q37796596 | ||
| Hypoxia and energetic tumour metabolism | Q37809288 | ||
| Targeting metabolic remodeling in glioblastoma multiforme | Q37840941 | ||
| Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. | Q39574525 | ||
| Carbonic anhydrase IX (CA9) modulates tumor-associated cell migration and invasion | Q39583766 | ||
| Regulation of proliferation-survival decisions during tumor cell hypoxia | Q39583941 | ||
| Changes of apoptosis, p53, and bcl-2 by irradiation in poorly differentiated thyroid carcinoma cell lines: a prognostic marker for the prospect of therapeutic success? | Q39740346 | ||
| Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. | Q39899643 | ||
| Distinct patterns of hypoxic expression of carbonic anhydrase IX (CA IX) in human malignant glioma cell lines | Q40237643 | ||
| Glycolytic glioma cells with active glycogen synthase are sensitive to PTEN and inhibitors of PI3K and gluconeogenesis | Q40371829 | ||
| Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. | Q40489574 | ||
| Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion | Q40519856 | ||
| Transcriptional response to hypoxia in human tumors | Q43727979 | ||
| Comparative measurements of hypoxia in human brain tumors using needle electrodes and EF5 binding | Q44783915 | ||
| The expressions of carbonic anhydrase 9 and vascular endothelial growth factor in astrocytic tumors predict a poor prognosis | Q45769304 | ||
| Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis | Q48678753 | ||
| Gliomas are driven by glycolysis: putative roles of hexokinase, oxidative phosphorylation and mitochondrial ultrastructure | Q48711381 | ||
| P-31 MR spectroscopy of normal human brain and brain tumors | Q49117410 | ||
| Brain phenotype of carbonic anhydrase IX-deficient mice. | Q51010100 | ||
| Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue. | Q51419552 | ||
| Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation. | Q51864014 | ||
| Epidemiology of brain tumors. | Q55465493 | ||
| Expression of hypoxia-related tissue factors in astrocytic gliomas. A multivariate survival study with emphasis upon carbonic anhydrase IX. | Q55468410 | ||
| Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix | Q59139010 | ||
| P433 | issue | 11 | |
| P921 | main subject | glioblastoma | Q282142 |
| P304 | page(s) | 1357-1366 | |
| P577 | publication date | 2012-10-16 | |
| P1433 | published in | Neuro-Oncology | Q15724471 |
| P1476 | title | Function of carbonic anhydrase IX in glioblastoma multiforme | |
| P478 | volume | 14 |
| Q57473451 | Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinoma |
| Q47903791 | Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo. |
| Q57286577 | C Pyruvate Transport Across the Blood-Brain Barrier in Preclinical Hyperpolarised MRI |
| Q34437996 | CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide |
| Q91826315 | Carbonic anhydrase IX and acid transport in cancer |
| Q38154554 | Carbonic anhydrase IX as an imaging and therapeutic target for tumors and metastases |
| Q41912194 | Co-amplification of phosphoinositide 3-kinase enhancer A and cyclin-dependent kinase 4 triggers glioblastoma progression |
| Q38130850 | Disrupting proton dynamics and energy metabolism for cancer therapy |
| Q89058816 | Elevation of the TP53 isoform Δ133p53β in glioblastomas: an alternative to mutant p53 in promoting tumor development |
| Q37690276 | Evaluation of Nonpeptidic Ligand Conjugates for SPECT Imaging of Hypoxic and Carbonic Anhydrase IX-Expressing Cancers |
| Q37710994 | Evaluation of a Carbonic Anhydrase IX-Targeted Near-Infrared Dye for Fluorescence-Guided Surgery of Hypoxic Tumors |
| Q39187880 | Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy. |
| Q38132855 | Histopathological determinants of tumor resistance: a special look to the immunohistochemical expression of carbonic anhydrase IX in human cancers |
| Q97419063 | Hypoxia, metabolism, and the circadian clock: new links to overcome radiation resistance in high-grade gliomas |
| Q37564738 | Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas |
| Q55342124 | Identification of radiation responsive genes and transcriptome profiling via complete RNA sequencing in a stable radioresistant U87 glioblastoma model. |
| Q92630473 | Inhibition of PP2A with LB-100 Enhances Efficacy of CAR-T Cell Therapy Against Glioblastoma |
| Q26849504 | Is carbonic anhydrase IX a validated target for molecular imaging of cancer and hypoxia? |
| Q33856008 | Membrane carbonic anhydrase IX expression and relapse risk in resected stage I-II non-small-cell lung cancer |
| Q55663256 | Molecular Markers of Therapy-Resistant Glioblastoma and Potential Strategy to Combat Resistance. |
| Q36031889 | Nanoparticles for Targeting Intratumoral Hypoxia: Exploiting a Potential Weakness of Glioblastoma |
| Q54664988 | New series of sulfonamides containing amino acid moiety act as effective and selective inhibitors of tumor-associated carbonic anhydrase XII. |
| Q38728290 | Newcastle disease virus degrades HIF-1α through proteasomal pathways independent of VHL and p53. |
| Q26749333 | Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction |
| Q57065394 | Paths for Improving Bevacizumab Available in 2018: The ADZT Regimen for Better Glioblastoma Treatment |
| Q38217449 | Peritumoral epilepsy: relating form and function for surgical success. |
| Q26749393 | Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis |
| Q38309196 | Prognostic marker analysis in pediatric intracranial ependymomas |
| Q58863152 | Synthesis and inhibition potency of novel ureido benzenesulfonamides incorporating GABA as tumor-associated carbonic anhydrase IX and XII inhibitors |
| Q34044274 | The Ketogenic Diet Alters the Hypoxic Response and Affects Expression of Proteins Associated with Angiogenesis, Invasive Potential and Vascular Permeability in a Mouse Glioma Model |
| Q47374256 | The Role of Hypoxia in Glioblastoma Invasion. |
| Q28069398 | Tumor Metabolism, the Ketogenic Diet and β-Hydroxybutyrate: Novel Approaches to Adjuvant Brain Tumor Therapy |
| Q35752332 | ZEB1 Promotes Invasion in Human Fetal Neural Stem Cells and Hypoxic Glioma Neurospheres. |
| Q38957110 | Zinc and zinc-containing biomolecules in childhood brain tumors. |
Search more.